Cleared Traditional

K232328 - Insignis Syringe Infusion System

K232328 is an FDA 510(k) clearance for Insignis Syringe Infusion System, manufactured by Innovative Health Sciences, LLC. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 211-day FDA review.

K232328 · Innovative Health Sciences, LLC · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2024
Decision
211d
Days
Class 2
Risk

K232328 is an FDA 510(k) clearance for the Insignis™ Syringe Infusion System. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Innovative Health Sciences, LLC (Chester, US). The FDA issued a Cleared decision on March 1, 2024 after a review of 211 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Innovative Health Sciences, LLC devices

FDA 510(k) Submission Details - K232328

510(k) Number K232328 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 03, 2023
Decision Date March 01, 2024
Days to Decision 211 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
82d slower than avg
Panel avg: 129d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 533
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K232328.
I.V. Administration Set
K242126 · Bq Plus Medical Co., Ltd. · Aug 2024
Disposable infusion set with needle
K232475 · Shandong Zhushi Pharmaceutical Group Co., Ltd. · May 2024
Disposable Extension Set
K222766 · Shandong Ande Healthcare Apparatus Co., Ltd. · Apr 2024
ResQ Administration Set
K231707 · Q For Plastic Industries · Jan 2024
Extension Set
K230528 · Medcaptain Life Science Co., Ltd. · Dec 2023
LILY Extension Tube and Needleless Connector
K222780 · Lily Medical Corporation · Nov 2023